Parkin DM, Pisani P, Ferlay J. Global cancer statistics. CAA Cancer Journal for Clinicians 1999; 49: 33–64.

American Cancer Society. Cancer facts and figures 2002. Atlanta, GA: American Cancer Society, 2002: 11–18.

Boyer M. Medical oncology. In D. Morris, J. Kearsley & C. Williams (Eds), Cancer: a comprehensive clinical guide. The Netherlands: Harwood Academic Publishers, 1998: 47–56.

Lichter AS. Radiation therapy. In MD. Abeloff, JO. Armitage, AS. Lichter & JE. Niederhuber (Eds), Clinical oncology (2nd ed). Beijing: Science Press, 2001: 446–447.

Zhou DH. Collection of experiences in tumour treatment. Guangdong: Guangdong Higher Education Press, 1997: 48–57.

Liu CA, Peng M. Dictionary of Chinese anti-cancer herbal medicine. Hubei: Hubei Science and Technology Press, 1994: Tumour Index 31–33.

Li PW. Comprehensive diagnosis and treatment for LC. Beijing: China Chinese Medicine Press, 2001: 561–589.

Guo XZ, Song CL. The regulation of herbal application for lung cancer. Liaoning Journal of Traditional Chinese Medicine 2002; 29(5): 273.

Han MQ, Liu JX, Gao H, et al. Effects of 24 Chinese medicinal herbs on nucleic acid, protein and cell cycle of human lung adenocarcinoma cell. Chinese Journal of Integrated Traditional and Western Medicine (Chin) 1995; 15(3): 147–149.

Lee SJ, Sung JH, Lee SJ, et al. Antitumour activity of a novel ginseng saponin metabolite in human pulmonary adenocarcinoma cells resistant to cisplatin. Cancer Lett 1999; 144(1): 39–43.

Sadava D, Ahn J, Zhan M, et al. Effects of four Chinese herbal extracts on drug-sensitive and multi-drug resistant small cell lung carcinoma cells. Cancer Chemotherapy and Pharmacology 2002; 49(4): 261–266.

Chen Q, Peng W, Qi S, Xu A. Apoptosis of human highly metastatic LUNG CANCER cell line 95-D induced by acutiaporberine, a novel bisalkaloid derived from Thalictrum acutifolium. Planta Med 2002; 68(6): 550–553.

Wang BX. Modern pharmacology of Chinese herbal medicine. Tianjin: Tianjin Science and Technology Press, 1997: 1153–1159.

Wang BX. Anti-cancer effects of polysaccharides. Studies on Ginseng 1991; (2) : 22.

Sato K, Mochizuki M, Saiki I, et al. Inhibition of tumour angiogenesis and metastasis by a saponin of Panax ginseng, ginsenoside-Rb2. Biol Pharm Bull 1994; 17(5): 635–639.

Mochizuki M, Yoo YC, Matsuzawa K, et al. Inhibitory effect of tumour metastasis in mice by saponins, ginsenoside-Rb2, 20 (R)- and 20(S)-ginsenoside-Rg3, of red ginseng. Biol Pharm Bull 1995; 18(9): 1197–1202

Wang BX. Research on ginseng. Tianjin: Tianjin Science and Technology Press, 1985: 297.

Gong GQ. Study on ginsenosides clearing free radical of superoxide anion. Journal of China Pharmaceutic University 1991; 22 (1): 41.

Wang JM. Effects of decoction and initial abstract of Notoginseng on natural killer cells and phagocyte in mice. Research of Chinese Patent Medicine 1987; 7(5): 5.

Gao H, Wang F, Lien EJ, Trousdale MD. Immunostimulating polysaccharides from Panax notoginseng. Pharm Res 1996; 13 (8): 1196–1200.

Wang BX. Modern pharmacology of Chinese herbal medicine. Tianjin: Tianjin Science and Technology Press, 1997: 816.

Liang J, Tang XF, Wei XL. Effects of gypenosides on tumour growth and immune functions in mice bearing Lewis lung cancer. The Journal of Pharmaceutical Practice 1999; 7(5): 279–281.

Zhou S. Adaptagenoid pharmacology of Rhizoma seu Herba Gynostemmatis and its compounds. Chinese Traditional and Herbal Drugs 1990; 20(7): 25.

Lin L, Zhang QP, Yu LX, et al. Laboratory study on antitumour effect of Sangenquliu Decoction for Lewis lung carcinoma. Journal of Zhejiang College of Traditional Chinese Medicine 1995; 19(1): 37–39.

Pang DX, Guo Y. Laboratory study on Sansi Compound for transplanted carcinoma. Journal of Zhejiang college of Traditional Chinese Medicine 1993; 17(4): 34–35.

Cheng XD, Guo F, Liu JX, et al. Study on therapeutic effect and immunological mechanism of Fuzheng Formula in mice with Lewis lung cancer. Chinese Journal of Integrated Traditional and Western Medicine (Chin) 1997; 17(2): 88–90.

Chang YF, Li J, Jin Y, et al. Effects of Qijia Mixture on cellular immune function in mouse Lewis lung carcinoma. Acta Universitatis Medicinalis Anhui 1999; 34(4): 266–267.

Zhou YF, Liu ZX, He HJ. Laboratory study of Fuzhengxiaoliu Mixture on anti-tumour metastasis in the lungs. Journal of Shandong University of Traditional Chinese Medicine 1999; 23 (5): 391–392.

Guo YD, Jing NC, Fan HX, et al. Laboratory study on treatment lung cancer with Feiaiping Decoction. Journal of Bethune Medical University 1997; 23(3): 282–283.

Onishi Y, Yamaura T, Tauchi K, et al. Expression of the antimetastatic effect induced by Juzen-taiho-to is based on the content of Shimotsu-to constituents. Biol Pharm Bull 1998; 21(7): 761–765.

Liu YL, Meng XT, He HJ, et al. Laboratory study of Feiliupingxiao Decoction for implanted tumour. Journal of Shandong College of Traditional Chinese Medicine 1996; 20(1): 40–42.

Ito H, Shimura K. Effects of a blended Chinese medicine, Xiaochi-hu-tang, on Lewis lung carcinoma growth and inhibition of lung metastasis, with special reference to macrophage activation. Japanese Journal of Pharmacology 1986; 41(3): 307–314.

Borchers AT, Sakai S, Henderson GL, et al. Shosaiko-to and other Kampo (Japanese herbal) medicines: a review of their immunomodulatory activities. J Ethnopharmacol 2000; 73(1–2) : 1–13.

Kaneko M, Kawakita T, Tauchi Y, et al. Augmentation of NK activity after oral administration of a traditional Chinese medicine, Xiao-chai-hu-tang (shosaiko-to). Immunopharmacol Immunotoxicol 1994; 16(1): 41–53.

Matsuura K, Kawakita T, Nakai S, et al. Role of B-lymphocytes in the immunopharmacological effects of a traditional Chinese medicine, Xiao-chai-hu-tang (shosaiko-to). Int J Immunopharmacol 1993 Feb; 15(2): 237–243.